Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells

Molecular and Cellular Biochemistry

Volumn 378, Issue 1-2, 2013, Pages 195-203

  Sun, Bo ^a   Rong, Rong ^a,b   Jiang, Hai ^c   Zhang, Hai ^a   Wang, Yipin ^a   Bai, Xiaoming ^a   Zhang, Min ^a   Ma, Juan ^a   Xia, Shukai ^a   Shu, Wei ^a   Zhang, Li ^a   Leng, Jing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; CREB; EP1 receptor; MMP2; PGE2

Indexed keywords

CREB1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; MMP2 PROTEIN, HUMAN; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; PTGER1 PROTEIN, HUMAN;

ARTICLE; BILE DUCT CARCINOMA; CALCIUM SIGNALING; ENZYME INDUCTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

CALCIUM SIGNALING; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DINOPROSTONE; ENZYME INDUCTION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE;

EID: 84886768730     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1610-1     Document Type: Article

References (27)

1. Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA (2006) Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res 66:6622-6627
2. Harris RE (2007) Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem 42:93-126
3. Rodrigues S, Bruyneel E, Rodrigue CM, Shahin E, Gespach C (2004) Cyclooxygenase 2 and carcinogenesis. Bull Cancer 91(Suppl 2):S61-S76
4. Kimura YN, Watari K, Fotovati A, Hosoi F, Yasumoto K, Izumi H, Kohno K, Umezawa K, Iguchi H, Shirouzu K, Takamori S, Kuwano M, Ono M (2007) Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci 98(2):2009-18
5. Stein-Werblowsky R (1974) Prostaglandin and cancer. Oncology 30:169-176
6. Xue X, Shah YM (2013) Hypoxia-inducible factor-2alpha is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer. Carcinogenesis 34:163-169
7. Ono M (2008) Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99:1501-1506
8. Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221-233
9. Paquette B, Therriault H, Desmarais G, Wagner R, Royer R, Bujold R (2011) Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. Br J Cancer 105:534-541
10. Barlow M, Edelman M, Glick RD, Steinberg BM, Soffer SZ (2012) Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. J Pediatr Surg 47:1223-1227
11. Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A (2005) COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26:1393-1399
12. Lu CC, Yang JS, Chiang JH, Hour MJ, Amagaya S, Lu KW, Lin JP, Tang NY, Lee TH, Chung JG (2012) Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling. Anticancer Res 32:2895-2903
13. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostor AG, Nie G, Lopata A, Salamonsen LA (2002) Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94:1466-1475
14. Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226
15. Mantamadiotis T, Papalexis N, Dworkin S (2012) CREB signalling in neural stem/progenitor cells: recent developments and the implications for brain tumour biology. BioEssays 34:293-300
16. Cheng JC, Esparza S, Sandoval S, Shankar D, Fu C, Sakamoto KM (2007) Potential role of CREB as a prognostic marker in acute myeloid leukemia. Future Oncol 3:475-480
17. Iguchi H, Mitsui T, Ishida M, Kanba S, Arita J (2011) cAMP response element-binding protein (CREB) is required for epidermal growth factor (EGF)-induced cell proliferation and serum response element activation in neural stem cells isolated from the forebrain subventricular zone of adult mice. Endocr J 58:747-759
18. Zhang L, Jiang L, Sun Q, Peng T, Lou K, Liu N, Leng J (2007) Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling. Mol Cell Biochem 305:19-26
19. Satpathy M, Shao M, Emerson R, Donner DB, Matei D (2009) Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. J Biol Chem 284:15390-15399
20. Melnikova VO, Mourad-Zeidan AA, Lev DC, Bar-Eli M (2006) Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem 281:2911-2922
21. Melnikova V, Bar-Eli M (2007) Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer Metastasis Rev 26:359-371
22. Han C, Michalopoulos GK, Wu T (2006) Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 207:261-270
23. Eschwege P, Ferlicot S, Droupy S, Ba N, Conti M, Loric S, Coindard G, Denis I, Ferretti L, Cornelius A, Legrand A, Bedossa P, Benoit G, Jardin A, Scardino P (2003) A histopathologic investigation of PGE2 pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder. Eur Urol 44:435-441
24. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C (1998) A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol 18:967-977
25. Kim YY, Lee EJ, Kim YK, Kim SM, Park JY, Myoung H, Kim MJ (2010) Anti-cancer effects of celecoxib in head and neck carcinoma. Mol Cells 29:185-194
26. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-501
27. Rundhaug JE, Simper MS, Surh I, Fischer SM (2011) The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev 30:465-480